1
Positive and Negative Affect Schedule (PANAS): psychometric properties of the online Spanish version in a clinical sample with emotional disorders | BMC Psychiatry | Full Text
The Positive and Negative Affect Schedule (PANAS) is the most widely and frequently used scale to assess positive and negative affect. The PANAS has been validated in several languages, and it has sho... [Read More]
1
Recommendations to improve the Positive and Negative Syndrome Scale (PANSS) based on item response theory
The adequacy of the Positive and Negative Syndrome Scale (PANSS) items in measuring symptom severity in schizophrenia was examined using Item Response Theory (IRT). Baseline P... [Read More]
1
The Minimum Clinically Important Difference in the Repeatable Battery for the Assessment of Neuropsychological Status
There is no established minimum clinically important difference (MCID) for the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) index and total scale scores. This study aimed... [Read More]
1
Reliable change and minimum clinically important difference (MCID) of the Repeatable Battery for the Assessment of Neuropsychology Status
ABSTRACT We compare reliable change scores and recently published anchor-based cutoffs for minimum clinically important difference (MCID) for the Repeatable Battery for the Assessment of Neurops... [Read More]
1
Brief Psychiatric Rating Scale
This chapter provides an overview of the clinical and research use of the BPRS (Brief Psychiatric Rating Scale). The aim here is to present sufficient information for a reader to appreciate the va... [Read More]
1
1
Minimum Clinically Important Difference in the Positive and Negative Syndrome Scale With Data From the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) | Psychiatrist.com
 ARTICLE ABSTRACTCONTEXT: Establishing the minimum clinically important difference in the Positive and Negative Syndrome Scale (PANSS) is important to the interpretation of the research and ... [Read More]
1
Abnormal Involuntary Movement Scale (AIMS)
The AIMS is a 12-item clinician-rated scale to assess severity of dyskinesias (specifically, orofacial movements and extremity and truncal movements) in patients taking neuroleptic medications. Add... [Read More]
1
CHAPTER 7 - The Wechsler Intelligence Scales in the Assessment of Psychopathology
Publisher SummaryThis chapter selects three disorders that have received extensive study with the Wechsler scales and in which cognitive function is an important consideration. The Wechsler scales sho... [Read More]
1
1
Frontiers | The Academic Resilience Scale (ARS-30): A New Multidimensional Construct Measure | Psychology
Resilience is a psychological construct observed in some individuals that accounts for success despite adversity. Resilience reflects the ability to bounce back, to beat the odds and is considered an ... [Read More]
1
Emotional abuse and emotional neglect subscales of the CTQ: Associations with each other, other measures of psychological maltreatment, and demographic variables
Emotional abuse and emotional neglect subscales of the CTQ: Associations with each other, other measures of psychological maltreatment, and demographic variables... [Read More]
1
Frontiers | Psychometric Properties of the Difficulties in Emotion Regulation Scale (DERS) and Its Short Forms in Adults With Emotional Disorders | Psychology
Objective: The Difficulties in Emotion Regulation Scale (DERS) is a widely-used self-report measure of subjective emotion regulation ability, as defined by a prominent clinically-derived model of emot... [Read More]
1
Abnormal Involuntary Movement Scale (AIMS) and Extrapyramidal Symptom Rating Scale (ESRS): cross-scale comparison in assessing tardive dyskinesia - PubMed
Assessing tardive dyskinesia (TD) has been complicated by the use of different research criteria and rating scales. We studied concordance between two commonly used scales, the Abnormal Involuntary Mo... [Read More]
1
Chemosensory Pleasure Scale: A New Assessment for Measuring Hedonic Smell and Taste Capacities | Chemical Senses | Oxford Academic
Abstract. Anhedonia, or the inability to experience pleasure, is a key clinical feature of many mental disorders such as depression and schizophrenia. Although [Read More]